PCH

Polar Capital Holdings Portfolio holdings

AUM $21.9B
1-Year Est. Return 83.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+83.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$1.14B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
300
New
Increased
Reduced
Closed

Top Buys

1 +$208M
2 +$193M
3 +$183M
4
LLY icon
Eli Lilly
LLY
+$175M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$157M

Top Sells

1 +$359M
2 +$253M
3 +$183M
4
MU icon
Micron Technology
MU
+$165M
5
GLW icon
Corning
GLW
+$149M

Sector Composition

1 Technology 50.1%
2 Healthcare 17.29%
3 Financials 14.82%
4 Communication Services 8.48%
5 Consumer Discretionary 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
226
Natera
NTRA
$29B
$1.91M 0.01%
+8,351
PCOR icon
227
Procore
PCOR
$8.56B
$1.69M 0.01%
23,200
-27,800
LIN icon
228
Linde
LIN
$236B
$1.29M 0.01%
3,020
-5,943
LEGN icon
229
Legend Biotech
LEGN
$3.41B
$1.15M 0.01%
52,893
-1,008
NTES icon
230
NetEase
NTES
$72.9B
$241K ﹤0.01%
1,750
RGEN icon
231
Repligen
RGEN
$7.25B
$202K ﹤0.01%
+1,230
LFST icon
232
Lifestance Health
LFST
$2.78B
$147K ﹤0.01%
20,870
-905
STXS icon
233
Stereotaxis
STXS
$202M
$40.6K ﹤0.01%
17,665
GDRX icon
234
GoodRx Holdings
GDRX
$737M
$27.1K ﹤0.01%
10,000
ABT icon
235
Abbott
ABT
$198B
-297,516
ADSK icon
236
Autodesk
ADSK
$52.4B
-4,100
AKRO
237
DELISTED
Akero Therapeutics
AKRO
-1,058,776
AVDL
238
DELISTED
Avadel Pharmaceuticals
AVDL
-3,999,338
AXS icon
239
AXIS Capital
AXS
$8.14B
-66,254
BSX icon
240
Boston Scientific
BSX
$113B
-654,258
CLBT icon
241
Cellebrite
CLBT
$3.3B
-432,443
CRH icon
242
CRH
CRH
$78.9B
-21,091
DASH icon
243
DoorDash
DASH
$76.6B
-540,369
DB icon
244
Deutsche Bank
DB
$65.4B
-212,757
DOCS icon
245
Doximity
DOCS
$4.75B
-401,393
EQH icon
246
Equitable Holdings
EQH
$11.4B
-107,591
ETN icon
247
Eaton
ETN
$147B
-76,475
EW icon
248
Edwards Lifesciences
EW
$50.2B
-317,886
EXAS icon
249
Exact Sciences
EXAS
$19.7B
-467,134
FHN icon
250
First Horizon
FHN
$11.7B
-231,600